QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
NASDAQ:BKYI

BIO-key International (BKYI) Stock Price, News & Analysis

$2.07
+0.07 (+3.50%)
(As of 02/28/2024 ET)
Today's Range
$2.05
$2.13
50-Day Range
$1.78
$3.60
52-Week Range
$1.74
$15.30
Volume
58,476 shs
Average Volume
218,807 shs
Market Capitalization
$1.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BIO-key International MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
3.03% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.39mentions of BIO-key International in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$3,400 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.20 out of 5 stars


BKYI stock logo

About BIO-key International Stock (NASDAQ:BKYI)

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

BKYI Stock Price History

BKYI Stock News Headlines

BIO-key International, Inc. (BKYI)
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
BIO-key Intl Stock (NASDAQ:BKYI) Insider Trades
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
BIO-key International Inc.
See More Headlines
Receive BKYI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
2/28/2024
Next Earnings (Estimated)
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:BKYI
Employees
51
Year Founded
N/A

Profitability

Net Income
$-11,910,000.00
Pretax Margin
-104.84%

Debt

Sales & Book Value

Annual Sales
$7.02 million
Book Value
$11.28 per share

Miscellaneous

Free Float
658,000
Market Cap
$1.60 million
Optionable
Optionable
Beta
0.37
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report














BKYI Stock Analysis - Frequently Asked Questions

How have BKYI shares performed in 2024?

BIO-key International's stock was trading at $3.00 at the beginning of the year. Since then, BKYI shares have decreased by 31.0% and is now trading at $2.07.
View the best growth stocks for 2024 here
.

Are investors shorting BIO-key International?

BIO-key International saw a decrease in short interest during the month of February. As of February 15th, there was short interest totaling 27,200 shares, a decrease of 54.4% from the January 31st total of 59,700 shares. Based on an average daily volume of 205,200 shares, the short-interest ratio is presently 0.1 days. Approximately 3.0% of the company's stock are sold short.
View BIO-key International's Short Interest
.

When is BIO-key International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our BKYI earnings forecast
.

How were BIO-key International's earnings last quarter?

BIO-key International, Inc. (NASDAQ:BKYI) posted its quarterly earnings data on Monday, November, 15th. The technology company reported ($2.34) EPS for the quarter, missing the consensus estimate of ($1.98) by $0.36. The technology company earned $1.30 million during the quarter. BIO-key International had a negative trailing twelve-month return on equity of 136.97% and a negative net margin of 90.82%.

When did BIO-key International's stock split?

Shares of BIO-key International reverse split on the morning of Thursday, December 21st 2023. The 1-18 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

What other stocks do shareholders of BIO-key International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BIO-key International investors own include Biocept (BIOC), T2 Biosystems (TTOO), iBio (IBIO), Onconova Therapeutics (ONTX), Acasti Pharma (ACST), Co-Diagnostics (CODX), Heat Biologics (HTBX), Tonix Pharmaceuticals (TNXP), VBI Vaccines (VBIV) and Inovio Pharmaceuticals (INO).

Who are BIO-key International's major shareholders?

BIO-key International's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include James David Sullivan, Michael W Depasquale and Michael W Depasquale.
View institutional ownership trends
.

How do I buy shares of BIO-key International?

Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BKYI) was last updated on 2/28/2024 by MarketBeat.com Staff